Concepedia

Peter J. Klauck

PJ

12

Publications

346

Citations

10

H-Index

2013

Active since

Affiliations

University of Colorado Anschutz Medical Campus(Current)

University of Colorado Denver

University of Colorado Cancer Center

Takeda (United States)

Millennium Engineering and Integration (United States)

Peter J. Klauck is an author at University of Colorado Anschutz Medical Campus specializing in tumor biology, cell biology, and cancer biology.

Top concepts

Publications per year

2013–2018

12

Publications

12

Rational Combination of a MEK Inhibitor, Selumetinib, and the Wnt/Calcium Pathway Modulator, Cyclosporin A, in Preclinical Models of Colorectal Cancer

Anna Spreafico, John J. Tentler, Todd M. Pitts et al. · Clinical Cancer Research · 2013 · 64 citations · Full text

Dual Pharmacological Targeting of the MAP Kinase and PI3K/mTOR Pathway in Preclinical Models of Colorectal Cancer

Todd M. Pitts, Timothy P. Newton, Erica L. Bradshaw‐Pierce et al. · PLoS ONE · 2014 · 52 citations · Full text

Cabozantinib Exhibits Potent Antitumor Activity in Colorectal Cancer Patient-Derived Tumor Xenograft Models via Autophagy and Signaling Mechanisms

Aaron J. Scott, John J. Arcaroli, Stacey M. Bagby et al. · Molecular Cancer Therapeutics · 2018 · 44 citations · Full text

Antitumor activity of the aurora a selective kinase inhibitor, alisertib, against preclinical models of colorectal cancer

Todd M. Pitts, Erica L. Bradshaw‐Pierce, Stacey M. Bagby et al. · Oncotarget · 2016 · 32 citations · Full text

Antitumor Activity of the MEK Inhibitor TAK-733 against Melanoma Cell Lines and Patient-Derived Tumor Explants

Lindsey N. Micel, John J. Tentler, Aik Choon Tan et al. · Molecular Cancer Therapeutics · 2014 · 28 citations · Full text

Rows per page

1–5 of 12